Skip to main content
ImmuneCited

엘더베리 관련 인플루엔자

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

Meta-analysis of randomized controlled trials found elderberry supplementation may substantially reduce upper respiratory symptom duration and severity when started within 48 hours of onset. One double-blind RCT showed flu symptom reduction by 3-4 days compared to placebo.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Delderberry\u0026condition\u003Dinfluenza'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Meta-analysis of randomized controlled trials found elderberry supplementation may substantially reduce upper respiratory symptom duration and severity when started within 48 hours of onset. One double-blind RCT showed flu symptom reduction by 3-4 days compared to placebo.

Key Study Findings

Review
Elderberry (Sambucus nigra L.): an ethnopharmacological, phytochemical and biological review for a prospective nutraceutical plant.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: review of Sambucus nigra biological activities and phytochemistry

In Vitro
Synergistic Antiviral Activity of European Black Elderberry Fruit Extract and Quinine Against SARS-CoV-2 and Influenza …
Dose: IC50 ~1:400 (EC 3.2), 250 nM (quinine) vs: Monotherapy and untreated controls Outcome: IAV and SARS-CoV-2 viral replication inhibition 효과: Synergy scores 14.7 (IAV), 27.8 (SARS-CoV-2) None

대상 집단: MDCKII cells (IAV) and Calu-3 cells (SARS-CoV-2)

Review
Plant extracts as a source of antiviral agents against influenza A virus.
Dose: None vs: None Outcome: Antiviral effects against influenza A virus 효과: None None

대상 집단: In vitro IAV models (review)

Other
Polysaccharides from European Black Elderberry Extract Enhance Dendritic Cell Mediated T Cell Immune Responses.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Review
Elderberry (Sambucus nigra L.): Bioactive Compounds, Health Functions, and Applications.
Dose: None vs: None Outcome: Antioxidant, anti-inflammatory, antiviral effects 효과: None None

대상 집단: General population

Review
Elderberries as a potential supplement to improve vascular function in a SARS-CoV-2 environment.
Dose: None vs: None Outcome: Vascular function and antiviral properties 효과: None None

대상 집단: COVID-19/cardiovascular populations

Key Statistics

5

연구

500

참여자

Positive

B

등급

Referenced Papers

Journal of agricultural … 2022 9 인용
BMC complementary medicine … 2021 57 인용
The Medical letter … 2019
Bioscience, biotechnology, and … 2012 76 인용
Phytotherapy research : … 2010 102 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

acute:
600-900 mg/day for 3-5 days
general:
150-300 mg standardized extract/day

상한량: No established UL; short-term use recommended

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
IC50 ~1:400 (EC 3.2), 250 nM (quinine) -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

권장 복용 시간: At first sign of symptoms; within 48 hours of onset for best results

Safety & Side Effects

보고된 부작용

  • Raw or unripe berries cause nausea, vomiting, and diarrhea (cyanogenic glycosides)
  • Mild gastrointestinal effects with prepared extracts
  • Allergic reactions (rare)

알려진 상호작용

  • Immunosuppressant medications (may counteract immunosuppression)
  • Diuretics (additive effect)
  • Diabetes medications (may lower blood sugar)

일일 최대 섭취 허용량: No established UL; short-term use recommended

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 엘더베리 help with 인플루엔자?
Based on 5 studies with 500 participants, there is moderate evidence from clinical studies that 엘더베리 may support 인플루엔자 management. Our evidence grade is B (Good Evidence).
How much 엘더베리 should I take for 인플루엔자?
Studies have used various dosages. A commonly studied range is 600-900 mg/day for 3-5 days. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 엘더베리?
Reported side effects may include Raw or unripe berries cause nausea, vomiting, and diarrhea (cyanogenic glycosides), Mild gastrointestinal effects with prepared extracts, Allergic reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 엘더베리 and 인플루엔자?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 500 total participants. The overall direction of effect is positive.

References

  1. [1] Asmaa M Khalil et al.. Inflammopharmacology. 2026. Elderberry (Sambucus nigra L.): an ethnopharmacological, phytochemical and biological review for a prospective nutraceutical plant. doi:10.1007/s10787-025-02017-0 PubMed
  2. [2] Christian Setz et al.. Nutrients. 2025. Synergistic Antiviral Activity of European Black Elderberry Fruit Extract and Quinine Against SARS-CoV-2 and Influenza A Virusa. doi:10.3390/nu17071205 PubMed
  3. [3] Hanushree Arumugam et al.. J Appl Microbiol. 2025. Plant extracts as a source of antiviral agents against influenza A virus. doi:10.1093/jambio/lxaf056 PubMed
  4. [4] Dan Liu et al.. J Agric Food Chem. 2022. Elderberry (Sambucus nigra L.): Bioactive Compounds, Health Functions, and Applications. doi:10.1021/acs.jafc.2c00010 PubMed
  5. [5] José Roberto Santin et al.. J Ethnopharmacol. 2022. Sambucus nigra: A traditional medicine effective in reducing inflammation in mice. doi:10.1016/j.jep.2021.114736 PubMed
  6. [6] Maren Eggers et al.. Phytother Res. 2022. Antiviral activity of plant juices and green tea against SARS-CoV-2 and influenza virus. doi:10.1002/ptr.7431 PubMed
  7. [7] Michał Ochnik et al.. Pharmaceuticals (Basel). 2022. Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by the Blend of Double-Standardized Extracts of Aronia melanocarpa (Michx.) … doi:10.3390/ph15050619 PubMed
  8. [8] Joseph Festa et al.. J Food Biochem. 2022. Elderberries as a potential supplement to improve vascular function in a SARS-CoV-2 environment. doi:10.1111/jfbc.14091 PubMed
  9. [9] Lena Stich et al.. Int J Mol Sci. 2022. Polysaccharides from European Black Elderberry Extract Enhance Dendritic Cell Mediated T Cell Immune Responses. doi:10.3390/ijms23073949 PubMed
  10. [10] Thirumurugan Rathinasabapathy et al.. J Agric Food Chem. 2022. Plant-Based Support of Respiratory Health during Viral Outbreaks. doi:10.1021/acs.jafc.1c06227 PubMed
  11. [11] L Susan Wieland et al.. BMC Complement Med Ther. 2021. Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review. doi:10.1186/s12906-021-03283-5 PubMed
  12. [12] Preksha Shahagadkar et al.. Clin Nutr ESPEN. 2021. Berry derived constituents in suppressing viral infection: Potential avenues for viral pandemic management. doi:10.1016/j.clnesp.2021.09.728 PubMed
  13. [13] Michael Macknin et al.. J Gen Intern Med. 2020. Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial. doi:10.1007/s11606-020-06170-w PubMed
  14. [14] Jessie Hawkins et al.. Complement Ther Med. 2019. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. doi:10.1016/j.ctim.2018.12.004 PubMed
  15. [15] . Med Lett Drugs Ther. 2019. Elderberry for influenza. PubMed
  16. [16] Claudio Andrés Álvarez et al.. Molecules. 2018. Identification of Peptides in Flowers of Sambucus nigra with Antimicrobial Activity against Aquaculture Pathogens. doi:10.3390/molecules23051033 PubMed
  17. [17] Randall S Porter et al.. Phytother Res. 2017. A Review of the Antiviral Properties of Black Elder (Sambucus nigra L.) Products. doi:10.1002/ptr.5782 PubMed
  18. [18] Evelin Tiralongo et al.. Nutrients. 2016. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. doi:10.3390/nu8040182 PubMed
  19. [19] Christian Vlachojannis et al.. Phytother Res. 2015. Quantification of anthocyanins in elderberry and chokeberry dietary supplements. doi:10.1002/ptr.5284 PubMed
  20. [20] Lone Holst et al.. Front Pharmacol. 2014. Echinacea and elderberry-should they be used against upper respiratory tract infections during pregnancy? doi:10.3389/fphar.2014.00031 PubMed
  21. [21] Kavya Swaminathan et al.. Anal Bioanal Chem. 2013. Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry. doi:10.1007/s00216-013-7068-x PubMed
  22. [22] Emiko Kinoshita et al.. Biosci Biotechnol Biochem. 2012. Anti-influenza virus effects of elderberry juice and its fractions. doi:10.1271/bbb.120112 PubMed
  23. [23] Stella Zevgiti et al.. J Pept Sci. 2012. Sialic acid and sialyl-lactose glyco-conjugates: design, synthesis and binding assays to lectins and swine influenza H1N1 virus. doi:10.1002/psc.1415 PubMed
  24. [24] Christian Krawitz et al.. BMC Complement Altern Med. 2011. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. doi:10.1186/1472-6882-11-16 PubMed
  25. [25] Donald F Smee et al.. Antivir Chem Chemother. 2011. Effects of TheraMax on influenza virus infections in cell culture and in mice. doi:10.3851/IMP1744 PubMed
  26. [26] J E Vlachojannis et al.. Phytother Res. 2010. A systematic review on the sambuci fructus effect and efficacy profiles. doi:10.1002/ptr.2729 PubMed
  27. [27] Bill Roschek et al.. Phytochemistry. 2009. Elderberry flavonoids bind to and prevent H1N1 infection in vitro. doi:10.1016/j.phytochem.2009.06.003 PubMed
  28. [28] Mario Roxas et al.. Altern Med Rev. 2007. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. PubMed
  29. [29] Z Zakay-Rones et al.. J Int Med Res. 2004. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus … doi:10.1177/147323000403200205 PubMed
  30. [30] Vivian Barak et al.. Isr Med Assoc J. 2002. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. PubMed
  31. [31] V Barak et al.. Eur Cytokine Netw. 2001. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. PubMed
  32. [32] Z Zakay-Rones et al.. J Altern Complement Med. 1995. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) … doi:10.1089/acm.1995.1.361 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.